• Feedback
  • RSS Feed
  • Sitemap
Ommcom News
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
Home Business

FDI In India’s Pharma Sector Crosses Rs 19,134 Crore During 2024-25

OMMCOM NEWS by OMMCOM NEWS
April 13, 2025
in Business

New Delhi: India’s pharmaceuticals and medical devices sector has seen a FDI inflow to the tune of Rs 11,888 crore from April to December in the financial year ended on March 31, 2025, apart from which 13 FDI proposals worth Rs 7,246.40 crore for brownfield projects during 2024-25 have been approved, taking the total FDI to Rs 19,134.4 crore, according to figures compiled by the Department of Pharmaceuticals.

The government’s Production Linked Incentive (PLI) Scheme, has turned out to be a transformative initiative for boosting domestic manufacturing, attracting investments, reducing reliance on imports and increasing exports, according to an official statement issued on Sunday.

One of the significant achievements under the PLI scheme has been the surpassing of targeted investments. While the initial commitment was Rs 3,938.57 crore, the actual realised investment has already reached Rs 4,253.92 crore (as of December 2024), the statement said.

Under the PLI scheme for Bulk Drugs, a total of 48 projects have been selected under the scheme, of which 34 projects have been commissioned for 25 bulk drugs as of December 2024.

Notable Projects Under the PLI Scheme for Bulk Drugs include the Penicillin G Project (Kakinada, Andhra Pradesh), with a Rs 1,910 crore investment and expected import substitution of Rs 2,700 crore per annum.

Clavulanic Acid Project at Nalagarh in Himachal Pradesh is also being implemented under the scheme with an investment of Rs 450 crore and is expected to result in an import substitution of Rs 600 crore per annum.

The PLI Scheme for Pharmaceuticals was approved by the Union Cabinet on February 24, 2021, with a financial outlay of Rs 15,000 crore and the production tenure from FY 2022-2023 to FY 2027-28, and provides financial incentive to 55 selected applicants for manufacturing of identified products under three categories for a period of six years. Under this scheme, high-value pharmaceutical products such as patented/off-patented drugs, biopharmaceuticals, complex generics, anti-cancer drugs, and auto-immune drugs, among others, are manufactured.

For pharmaceuticals, the initiative aims to reduce import dependence on Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs), strengthening India’s manufacturing base. By promoting production and innovation, it boosts domestic capabilities and global competitiveness.

The PLI Scheme for Medical Devices was launched to support domestic manufacturing of high-end medical equipment and reduce reliance on imports. The scheme provides financial incentives to manufacturers in key segments such as radiology, imaging, cancer care, and implants.

The period of the scheme is from financial year 2020-21 to financial year 2027-28 with total financial outlay of Rs. 3,420 crore. Under the scheme, financial incentive is given to selected companies, at the rate of 5 per cent of the incremental sales of medical devices manufactured in India and covered under the target segments of the scheme, for a period of five years.

The Indian pharmaceutical industry continues to play a crucial role in manufacturing high-quality, cost-effective medicines for both domestic and global markets, marked by its dominance in branded generic medicines, competitive pricing, and a robust network of indigenous brands, the statement added.

(IANS)

ShareTweetSendSharePinShareSend
Previous Post

Teacher Suspended For Allegedly Beating Student At Dhenkanal School

Next Post

Former Kerala Government Lawyer Accused In Rape Cases Dies By Suicide

Related Posts

Economy
Business

Strong GDP Growth Reinforces India’s Position As Fastest-Growing Major Economy

May 30, 2025
FM Sitharaman
Business

Centre Okays Additional Rs 81,735 Crore As Tax Devolution To States: FM Sitharaman

May 30, 2025
gross domestic product
Business

Govt Succeeds In Keeping Fiscal Deficit In Check At 4.8 Pc Of GDP For FY25

May 30, 2025
Adani Energy Solutions
Business

Adani Energy Solutions Bags Rs 1,660 Crore Transmission Project In Maharashtra

May 30, 2025
GDP Growth
Business

India Clocks 6.5 Pc GDP Growth In 2024-25, Q4 Growth Surges To 7.4 Pc

May 30, 2025
Indian stock market
Business

Stock Market Ends Lower Ahead Of Key GDP Data

May 30, 2025
Next Post

Former Kerala Government Lawyer Accused In Rape Cases Dies By Suicide

IPL 2025: Jaiswal's Half-Century Powers RR To 173/4 Against RCB

Woman's Body Exhumed After 135 Days In UP's Mau After Sister's Startling Revelations

Khimji
  • Feedback
  • RSS Feed
  • Sitemap

© 2025 - Ommcom News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

© 2025 - Ommcom News. All Rights Reserved.